Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Robert A. Kyle, S. Vincent Rajkumar

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations

Abstract

In 1978, the term "monoclonal gammopathy of undetermined significance" (MGUS) was introduced. MGUS is defined as a serum monoclonal (M) protein less than 3.0 g/dL; less than 10% plasma cells in the bone marrow, if done; little or no M protein in the urine; and absence of lytic bone lesions, anemia, hypercalcemia or renal insufficiency. This article discusses the recognition, prevalence, natural history, and progression of MGUS. Management of the disease is discussed along with its association with other disorders. Information on smoldering multiple myeloma is included.

Original languageEnglish (US)
Pages (from-to)1093-1113
Number of pages21
JournalHematology/Oncology Clinics of North America
Volume21
Issue number6
DOIs
StatePublished - Dec 2007

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma'. Together they form a unique fingerprint.

Cite this